References
- Maxon HR, Smith HS. Radioiodine-131 in the diagnosis and treatment of metastatic well differentiated thyroid cancer. Endocrinol Metab Clin North Am 1990; 19: 685–718
- Rubino C, De Vathaire F, Dottorini ME, Hall P, Schvartz C, Couette JE, et al. Second primary malignancies in thyroid cancer patients. Br J Cancer 2003; 89(9)1638–44
- Pacini F, Schlumberger M, Harmer C, Berg G, Cohen O, Duntas L, et al. Post-surgical use of radioiodine 131I in patients with papillary and follicular thyroid cancer and the issue of remnant ablation: A consensus report. Eur J Endocrinol 2005; 153: 651–9
- Nyström E, Berg G, Jansson S, Lindstedt G, Törring O, Valdemarsson S. Thyreotoxicos hos vuxna. Nyström E, Nycomed AB editors. StockholmSweden; 1999.
- Berg G. The structure of human thyroglobulin. J Ultrastruct Res 1975; 53: 113–8
- Dohan O, De la Veija A, Paroder V, Riedel C, Artani M, Reed Mia, et al. The sodium/iodide symporter (NIS): Characterization, regulation, and medical significance. Endocr Rev 2003; 24(1)48–77
- Coelho SM, Corbo R, Buesco A, Carvalho DP, Vaisman M. Retinoic acid in patients with radioiodine non-responsive thyroid carcinoma. J Endocrinol Invest 2004; 27(4)334–9
- Hansson M, Berg G, Larsson A, Nyström E, Isaksson M. X-ray fluorescence analysis for determination of iodine concentration in the thyroid. A methodological study. Int J Body Composition Res 2004; 2: 155–63
- Gérard A-C, Daumerie C, Mestdagh C, Gohy S, De Burbure S, Costagliola S, et al. Correlation between the loss of thyroglobulin iodination and the expression of thyroid-specific proteins involved in iodine metabolism in thyroid carcinomas. J Clin Endocrinol & Metab 2003; 88: 4977–83
- Van der Molen A, Thomsen HS, Morcos SK, Members of the Contrast Media Safety Committee of the European Society of Urogenital Radiology (ESUR). Effect of iodinated contrast media on thyroid function in adults. Eur Radiol 2004; 14: 902–7
- Milakovic M, Berg G, Eggertsen R, Nyström E. Effect of lifelong iodine supplementation on thyroid 131-I uptake: A decrease in uptake in euthyroid but not hyperthyroid individuals compared to observations 50 years ago. Eur J Clin Nutr 2006; 60: 210–213
- Larsson LG. Studies on radioiodine treatment of thyrotoxicosis with special reference to the behaviour of the radioiodine tracer tests. Acta Radiol 1955; 126: 1–164
- Luster M, Lippi F, Jarzab B, Perros P, Lassmann M, Reiners C, Pacini F. rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: A comprehensive review. Endocr Rel Cancer 2005; 12: 49–64
- Rawson RW, Rall JE, Peacook W. Limitations and indications in the treatment of cancer of the thyroid with radioactive iodide. J Clin Endocrinol Metab 1951; 11: 1128–31
- Jeevanram RK, Shah DH, Sharma SM, Ganatra RD. Influence of initial large dose on subsequent uptake of therapeutic radioiodine in thyroid cancer patients. Nucl Med Biol 1986; 13: 277–9
- Nilsson M, Björkman U, Ekholm R, Ericson LE. Iodide transport in primary cultured thyroid follicle cells: Evidence of a TSH-regulated channel mediating iodide efflux selectively across the apical domain of the plasma membrane. Eur J Cell Biol 1990; 52: 270–81
- Postgård P, Himmelman J, Lindencrona U, Bhogal N, Wiberg D, Berg G, et al. Stunning of iodide transport by 131I irradiation in cultured thyroid epithelial cells. J Nucl Med 2002; 43: 828–34
- Lassmann M, Luster M, Hanscheid H, Reiners C. Impact of 131I diagnostic activities on the biokinetics of thyroid remnants. J Nucl Med 2004; 45: 619–25
- Medvedec M. Thyroid stunning in vivo and in vitro. Nucl Med Comm 2005; 26: 731–5